UBS Maintains Neutral on Lineage, Raises Price Target to $45
Benzinga Newsdesk 3 months ago
NewsPrice TargetAnalyst Ratings
UBS analyst Michael Goldsmith maintains Lineage (NASDAQ:LINE) with a Neutral and raises the price target from $35 to $45.
UBS analyst Michael Goldsmith maintains Lineage (NASDAQ:LINE) with a Neutral and raises the price target from $35 to $45.